Overview:
Providing detailed care to patients suffering from damaged vessels during an operation is of utmost importance as this can trigger substantial blood loss. Hemostasis is the formation of blood clots near the site of the injury. Surgical instruments that help in controlling blood loss by forming temporary clots are known as hemostats. It is also known as arterial forceps, hemostatic clamp, and pean after Jules-Émile Péan. The process is often implemented at an early stage of incision to close blood vessels from ligation.
Increasing number of surgical procedures, innovation, rising cases of wounds & accidents, and demand for blood loss management are factors that can boost the global hemostats market. All these are getting amply backed by technological advancements. Factors such as these will take the hemostats market forward in the coming years.
Competitive Landscape:
The global hemostats market depends on strategy-making policies of several companies such as B. Braun Melsungen AG (Germany), CR Bard, Inc. (US), Integra LifeSciences (US), Baxter International, Inc. (US), Teleflex (US), Marine Polymer Technologies, Inc. (US), Pfizer, Inc. (US), Stryker (US), Z-Medica LLC (US), Ethicon, Inc. (US), Anika Therapeutics, Inc. (US), Gelita Medical GmbH (Germany), and Integra Lifesciences Corporation (US). These companies have been profiled by MRFR in their report which contains a detailed analysis of their recent performances.
In April 2019, Baxter International Inc. announced that their hemostatic product Floseal Hemostatic Matrix received recently received clearance from the FDA. This Floseal is easy to prepare in the operating room as it has 20% fewer components. During the operation, preventing blood loss is of utmost importance which can now be done quicker with this product.
Segmental Analysis:
MRFR’s report on the global hemostats market can be segmented by product type, instrument type, application, and end-user. The report is more of an in-depth analysis of the market for a better predictive view of the coming years.
By product type, the hemostats market consists combination-based, thrombin-based, gelatin-based, oxidized regenerated cellulose-based, tissue sealants, collagen-based hemostat, adhesion prevention products, cyanoacrylate-based tissue adhesives, and others. The tissue sealants segment includes fibrin sealants and protein-based sealants.
Based on the instrument type, the hemostats market can be segmented into kelly & crile hemostatic forceps, halstead mosquito hemostatic forceps, and rochester-carmalt hemostatic forceps.
Based on the application, the hemostats market comprises orthopedic surgery, cardiovascular surgery, gynecological surgery, general surgery, neurological surgery, reconstructive surgery, and other surgeries.
Based on end-users, the hemostats market comprises community healthcare, clinics, hospitals, ambulatory surgery centers, and others.
Regional Analysis:
The global types of hemostats market, as discussed by MRFR in their report, includes North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The market in North America is the largest revenue earner among all regions. The inclusion of advanced medical technologies, rising awareness, robust healthcare sector, and favorable compensation are inspiring several surgical procedures. This is ensuring high growth rate for the regional market. In addition, reimbursement policies and high expenditure capacities are factors that can positively impact the North American market.
Europe’s market is the second largest one and several other factors such as cardiovascular disorders, increasing number of surgeries and surging inclusion of advanced treatment procedures can promote the market further.
The APAC market is going to profit substantially owing to investments made in the infrastructural development of healthcare sectors in emerging economies. The sector is now eyeing for an optimal treatment condition due to which latest products are getting approved quite easily. At the same time, increasing disposable income is creating scope for the market to expand. The region has also made a name for itself as a medical tourism hub which can support market growth.
The MEA market can get restrained during the forecast period owing to the presence of poor economies and lack of technical knowledge.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
